BlackRock Amends Revolution Medicines Stake, Signals Continued Confidence
Ticker: RVMDW · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1628171
| Field | Detail |
|---|---|
| Company | Revolution Medicines, Inc. (RVMDW) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns a big chunk of Revolution Medicines, good sign for the stock!**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership in Revolution Medicines, Inc. as of December 31, 2023. This filing indicates that BlackRock, a major institutional investor, continues to hold a significant stake in Revolution Medicines, Inc. This matters to investors because large institutional holdings like BlackRock's can signal confidence in the company's future prospects and stability, potentially influencing other investors' perceptions and the stock's liquidity.
Why It Matters
This filing shows that a major institutional investor, BlackRock, maintains a significant position in Revolution Medicines, Inc., which can be seen as a vote of confidence in the company's long-term potential.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate negative risks for the company.
Analyst Insight
An investor might view BlackRock's continued holding as a positive signal, suggesting stability and institutional confidence in Revolution Medicines, Inc., but should conduct further due diligence before making investment decisions.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Revolution Medicines, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., identified by CIK 0001364742.
What is the subject company whose securities are being reported?
The subject company is Revolution Medicines, Inc., identified by CIK 0001628171.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of Revolution Medicines, Inc. is 76155X100.
As of what date does the reported ownership information apply?
The reported ownership information is as of December 31, 2023, which is the 'Date of Event Which Requires Filing of this Statement'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Revolution Medicines, Inc. (RVMDW).